Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

BREVIBLOC

ESMOLOL HYDROCHLORIDE

Standard Dose
250MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview BREVIBLOC is listed in Drugs@FDA under application 019386 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient ESMOLOL HYDROCHLORIDE Form and strength INJECTABLE; INJECTION - 250MG/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2025-09-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview BREVIBLOC is listed in Drugs@FDA under application 019386 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient ESMOLOL HYDROCHLORIDE Form and strength INJECTABLE; INJECTION - 250MG/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2025-09-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.